Poland rejects Bitcoin reserves citing risk over security and stability, while election may shift crypto policy.
Roche’s subsidiary Genentech has shared positive Phase III data with the US Food and Drug Administration (FDA) as the company targets the billion-dollar lupus market for its CD20-targeting drug Gazyva ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback